Multiple Myeloma

Multiple Myeloma is a malignant plasma cell neoplasm characterized by clonal proliferation of terminally differentiated B-lymphocytes in the bone marrow, leading to end-organ damage through monoclonal protein production, bone lytic lesions, and renal impairment.

17K

Publications

1.1M

Citations

62.4K

Authors

7.6K

Institutions

Publications per year

2017–2026

4.9K

Authors

62.4K

  1. KC
    Kenneth C. Anderson

    Dana-Farber Cancer Institute, United States

    643 publications · 97.7K citations

    153

    h-index

  2. PG
    Paul G. Richardson

    Dana-Farber Cancer Institute, United States

    547 publications · 85.7K citations

    137

    h-index

  3. NC
    Nikhil C. Munshi

    Dana-Farber Cancer Institute, United States

    397 publications · 59.5K citations

    126

    h-index

  4. JF
    Jesús F. San Miguel

    Universidad de Salamanca, Spain

    460 publications · 75.5K citations

    121

    h-index

  5. PM
    Philippe Moreau

    Centre Hospitalier Universitaire de Nantes, France

    467 publications · 66.7K citations

    118

    h-index

1–5 of 62.4K

Venues

  1. Blood

    2.1K publications · 209.8K citations

    224

    h-index

  2. Journal of Clinical Oncology

    507 publications · 58.2K citations

    130

    h-index

  3. Leukemia

    437 publications · 45.5K citations

    115

    h-index

  4. British Journal of Haematology

    BJH · 839 publications · 52.5K citations

    109

    h-index

  5. PubMed

    Repository · 1.1K publications · 50.5K citations

    98

    h-index

1–5